A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Д. А. Шапиро, Mitchell L. Shiffman et al.|New England Journal of Medicine|2016Cited by 1.1k
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitisJimmy Z. Liu, Javier Gutierrez‐Achury, Tom H. Karlsen et al.|Nature Genetics|2013Cited by 398
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Pietro Lampertico, Roberta D’Ambrosio et al.|Journal of Hepatology|2020Cited by 392
Iron levels in polarized macrophages: Regulation of immunity and autoimmunityStefania Recalcati, Gaetano Cairo, Massimo Locati et al.|Autoimmunity Reviews|2012Cited by 142
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel diseaseMarisa Iborra, Silvio Danese, Francesca Bernuzzi et al.|Clinical & Experimental Immunology|2013Cited by 130